Launched in Q1 2023, Cellular Origins is using its proprietary technology to address barriers associated with the manufacture of advanced therapies that are in late-stage development, enabling commercial manufacturing without process change. The platform has been developed for flexibility, with the ability to integrate current workflows and existing instrumentation with future process innovation.